Saltar al contenido
Global sound
The Bio Report

The Bio Report

Outsmarting Resistance with Rhythm

· 38 min · Episodio 166

Notas del episodio

Pancreatic cancer remains one of oncology’s deadliest diagnoses, with standard treatments often offering only transient tumor shrinkage at the cost of grueling side effects and rapid resistance. Immuneering is using transcriptomic and informatics tools to design a MEK inhibitor dosed in intense daily pulses rather than continuously. This approach aims to restore a more normal signaling rhythm in healthy cells while repeatedly ambushing tumors. Ben Zeskind, CEO of Immuneering, discusses how the company is using its informatics-driven dosing regimen to re-engineer targeted cancer therapy so it extends survival, delays resistance, and is better tolerated.

Web: thebioreport.podbean.com

En directo, última hora: 14.704 canciones en 6.225 emisoras de 145 países

Descubre el mundo a través de la radio

Más formas de descubrir (7)

¿Has oído algo bueno? Guárdalo o ábrelo directamente en Spotify.

★ Artista de la semana El que más sube en la radio esta semana
¿Tu canción aquí? Desde € 9 por semana →
Super FM -Brașov 93,8 FMSeguir escuchando